Completed
A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy
NCT00298038
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
- Locations
-
Not specified